Iranian Journal of Nuclear Medicine

Author = Simindokht Shirvani-Arani

Development and assessment of 153Sm-zoledronate complex as a possible bone pain palliative agent

Volume 25, Issue 2, July 2017, Pages 81-91

Mirsaeed Nikzad; Amir Reza Jalilian; Simindokht Shirvani-Arani; Masood Arabieh; Saeed Shanesazzadeh; Hamid Golchoobian

Production of no-carrier-added Ho-166 for targeted therapy purposes

Volume 25, Supplement 1, February 2017, Pages 15-20

Sara Vosoughi; Simindokht Shirvani-Arani; Ali Bahrami-Samani; Nafiseh Salek; Amir Reza Jalilian

Comparative studies of extraction chromatography and electro-amalgamation separation to produce no-carrier added 177Lu by Tehran research reactor

Volume 25, Issue 1, January 2017, Pages 23-33

Nafise Salek; Mojtaba Shamsaei; Mohammad Ghannadi Maragheh; Simindokht Shirvani Arani; Ali Bahrami Samani

Radiosynthesis and evaluation of ytterbium-175 labeled bleomycin as therepeutic agent

Volume 22, Issue 2, June 2014, Pages 40-45

Ayuob Aghanejad; Amir Reza Jalilian; Ali Bahrami-Samani; Simindokht Shirvani-Arani; Sedigheh Moradkhani

Production and quality control of 166Ho-Chitosan for therapeutic applications

Volume 18, Issue 2, December 2010, Pages 1-8

Samaneh Zolghadri; Amir Reza Jalilian; Hassan Yousefnia; Ali Bahrami-Samani; Simindokht Shirvani-Arani; Mohammad Mazidi; Mehdi Akhlaghi; Mohammad Ghannadi-Maragheh

Production, quality control and biological evaluation of 153Sm-EDTMP in wild-type rodents

Volume 17, Issue 2, December 2009, Pages 12-19

Ali Bahrami-Samani; Mohammad Ghannadi-Maragheh; Amir Reza Jalilian; Simindokht Shirvani-Arani; Moein Meftahi; Sedigheh Moradkhani